Kathleen Schoemaker Insider Profile
4 Followers
Kathleen Schoemaker, Ten Percent Owner at Veracyte, holds 0.00 shares in Cadence Pharma (Ticker: CADX), holds 33.89K shares in Achaogen (Ticker: AKAOQ), holds 13.00K shares in Dicerna Pharma (Ticker: DRNA).
Kathleen Schoemaker's Trading History
| CADXCadence Pharma | Mar 21, 2014 | ― | Uninformative Sell | 146.20M | ― | |
| AKAOQAchaogen | Mar 17, 2014 | ― | Uninformative Buy | ― | $847.25 | |
| DRNADicerna Pharma | Feb 04, 2014 | ― | Uninformative Buy | 296.76K | $497.01K | |
| VCYTVeracyte | Nov 04, 2013 | Ten Percent Owner | Uninformative Buy | ― | $545.75K | |
| EVOKEvoke Pharma | Sep 30, 2013 | ― | Uninformative Buy | ― | $266.82K | |
| TBRATobira Therapeutics | Aug 28, 2013 | ― | Uninformative Buy | ― | $1.35M | |
| OCRXOcera Therapeutics | Jul 15, 2013 | ― | Informative Buy | 7.99M | $6.31M | |
| ESPREsperion | Jul 02, 2013 | ― | Uninformative Buy | ― | $112.10K | |
| ~ACHNAchillion Pharmaceuticals | Jan 18, 2013 | ― | Uninformative Sell | ― | $1.65M | |
| CLPMCelator Pharmaceuticals | Jan 14, 2013 | ― | Informative Buy | ― | $67.88M | |
| DRTXDurata | Jul 24, 2012 | ― | Uninformative Buy | ― | ― | |
| OREXQOrexigen | Dec 22, 2011 | ― | Informative Buy | 680.26K | $253.22 | |
| CLVSQClovis Oncology | Nov 21, 2011 | ― | Uninformative Buy | ― | $765.20 | |
| ZGNXZogenix | Sep 20, 2011 | ― | Informative Buy | 7.00M | $4.52M | |
| ALIMAlimera | Jun 03, 2011 | ― | Uninformative Sell | ― | $225.98K | |
| PRTKParatek Pharmaceuticals | Jan 30, 2009 | ― | Informative Sell | 238.75K | $151.36K | |
| VOLCVolcano Corp | ― | ― | ― | ― | ||
| SOMXSomaxon Pharmaceuticals | ― | ― | ― | ― | ||
| SNTSSantarus | ― | ― | ― | ― | ||
| VNDAVanda | ― | Ten Percent Owner | ― | $80.27K | ||
| SNMXSenomyx | ― | ― | ― | $91.18K | ||
| NUVANuVasive | ― | ― | ― | $318.00K |
You May Also Like
Kathleen Schoemaker insider profile FAQ
What is the percentage of profitable transactions made by Kathleen Schoemaker?
The percentage of profitable transactions made by Kathleen Schoemaker is 34%.
What is the average return per transaction made by Kathleen Schoemaker?
The average return per transaction made by Kathleen Schoemaker is 10.40%.
What stocks does Kathleen Schoemaker hold?
Kathleen Schoemaker holds: VCYT, OCRX, CLVSQ, CLPM, ZGNX, ~ACHN, ESPR, TBRA, NUVA, SNMX, VNDA, AKAOQ, DRNA, OREXQ, ALIM, EVOK, CADX, SNTS, SOMX, PRTK, VOLC, DRTX stocks.
What was Kathleen Schoemaker’s latest transaction?
Kathleen Schoemaker’s latest transaction was an Uninformative Sell of $146.20M.
What was Kathleen Schoemaker's most profitable transaction?
Kathleen Schoemaker’s most profitable transaction was an Informative Buy of EVOK stock on September 24, 2013. The return on the trade was 453.90%.
What is Kathleen Schoemaker's role in Veracyte?
Kathleen Schoemaker's role in Veracyte is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
